The drug has a marketing authorisation in a pressurised metered-dose inhaler (pMDI), as a maintenance dual bronchodilator to relieve symptoms in adults with COPD. Bevespi, which is taken twice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback